KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $14.6 billion.

  • Abbott Laboratories' Total Current Liabilities fell 214.74% to $14.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 billion, marking a year-over-year decrease of 214.74%. This contributed to the annual value of $14.2 billion for FY2024, which is 228.31% up from last year.
  • Per Abbott Laboratories' latest filing, its Total Current Liabilities stood at $14.6 billion for Q3 2025, which was down 214.74% from $13.4 billion recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Total Current Liabilities ranged from a high of $15.5 billion in Q4 2022 and a low of $12.4 billion during Q2 2022
  • For the 5-year period, Abbott Laboratories' Total Current Liabilities averaged around $13.6 billion, with its median value being $13.4 billion (2025).
  • Per our database at Business Quant, Abbott Laboratories' Total Current Liabilities skyrocketed by 2544.6% in 2021 and then plummeted by 1063.98% in 2023.
  • Quarter analysis of 5 years shows Abbott Laboratories' Total Current Liabilities stood at $13.1 billion in 2021, then grew by 18.19% to $15.5 billion in 2022, then dropped by 10.64% to $13.8 billion in 2023, then rose by 2.28% to $14.2 billion in 2024, then increased by 3.0% to $14.6 billion in 2025.
  • Its last three reported values are $14.6 billion in Q3 2025, $13.4 billion for Q2 2025, and $13.0 billion during Q1 2025.